People · Operator
Named in public records as an officer, director or promoter · active 2021–2021 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| GLO Pharma, Inc. | — | Pharmaceuticals | Series C | $60.4M | $1.2B | 2021 |
Vimla Black-Gupta at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Vimla Black-Gupta on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brent Saunders | 1 | 5 |
| Lauren Otsuki | 1 | 4 |
| Nicole Quinn | 1 | 4 |
| Scott Glenn | 1 | 4 |
| Todd Jackson | 1 | 2 |
| Douglas Wall | 1 | 2 |
| Jana Messersmith | 1 | 1 |
| Dayna Quanbeck | 1 | 1 |
| Marla Beck | 1 | 1 |
| Maureen Case | 1 | 1 |
| Fabian Seelbach | 1 | 1 |
| Carol Shen | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.